Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection

This study has been completed.
Sponsor:
Information provided by:
GlobeImmune
ClinicalTrials.gov Identifier:
NCT00124215
First received: July 25, 2005
Last updated: May 3, 2010
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)